Yuani Watson

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: Germany

Consulting Services

Pharma-CRO-Device Hospital-Pharmacy-Insurance Grant Submission

Areas Of Interest

Dysautonomia-Orthostatic Hypotension Syndrome Influenza A viruses Mild Concussion Instructor, Family Planning Eruptions, Maculopapular Drug OTC Deficiencies Ferrous Hemoglobin B Kinase, I-kappa Ileitis, Terminal alpha 2 Macroglobulin Receptor Cyst, Jaw Bible Abscess, Hepatic, Amebic Acceptability of Healthcare Actomyosin Subfragments Organic Cation Carnitine Transporter 2 Radiatum, CA3 Stratum Contractile Proteins Valine Prolamins Dorsal Horns Granulomatous Vasculitis, Eosinophilic

Professional Narrative

Dr. Yuani Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2016
Director Medicine, Amgen 2016

Education

Doctor of medicine, Yale School of Medicine 1994
Bachelor of science in nursing, Harvard Medical School 2014

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :